Found: 43
Select item for more details and to access through your institution.
Overexpression of cyclin D1 is rare in human prostate carcinoma.
- Published in:
- Prostate, 1999, v. 38, n. 1, p. 40, doi. 10.1002/(SICI)1097-0045(19990101)38:1<40::AID-PROS5>3.0.CO;2-I
- By:
- Publication type:
- Article
Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.
- Published in:
- Prostate, 1998, v. 34, n. 2, p. 145, doi. 10.1002/(SICI)1097-0045(19980201)34:2<145::AID-PROS10>3.0.CO;2-I
- By:
- Publication type:
- Article
Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines.
- Published in:
- BJU International, 2008, v. 102, n. 10, p. 1458, doi. 10.1111/j.1464-410X.2008.07826.x
- By:
- Publication type:
- Article
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 713, doi. 10.3390/vaccines12070713
- By:
- Publication type:
- Article
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 969, doi. 10.3390/vaccines11050969
- By:
- Publication type:
- Article
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1328512
- By:
- Publication type:
- Article
Evolving Treatment Algorithms for Advanced Non-small-cell Lung Cancer: 2009 Looking Toward 2012.
- Published in:
- Chinese Journal of Lung Cancer, 2010, v. 13, n. 3, p. 238, doi. 10.3779/j.issn.1009-3419.2010.03.16
- By:
- Publication type:
- Article
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer.
- Published in:
- Nature Medicine, 2015, v. 21, n. 9, p. 1038, doi. 10.1038/nm.3930
- By:
- Publication type:
- Article
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 60, doi. 10.1016/j.cllc.2021.10.002
- By:
- Publication type:
- Article
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 541, doi. 10.1016/j.cllc.2021.05.001
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
- By:
- Publication type:
- Article
Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non--Small-Cell Lung Cancer: SWOG S0533.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 5, p. 340, doi. 10.1016/j.cllc.2014.12.014
- By:
- Publication type:
- Article
Bridging Tumor Genomics to Patient Outcomes Through an Integrated Patient-Derived Xenograft Platform.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 3, p. 165, doi. 10.1016/j.cllc.2015.03.001
- By:
- Publication type:
- Article
Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non--Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 1, p. 1, doi. 10.1016/j.cllc.2013.10.001
- By:
- Publication type:
- Article
Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Chemotherapy Outcomes by Histologic Subtypes of Non—Small-Cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 6, p. 627, doi. 10.1016/j.cllc.2013.06.010
- By:
- Publication type:
- Article
Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 33, doi. 10.3816/CLC.2011.n.004
- By:
- Publication type:
- Article
Evolving Treatment Algorithms for Advanced Non–Small-Cell Lung Cancer: 2009 Looking Toward 2012.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 6, p. 392, doi. 10.3816/CLC.2009.n.074
- By:
- Publication type:
- Article
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 940, doi. 10.3390/cancers16050940
- By:
- Publication type:
- Article
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
- Published in:
- Prostate, 2007, v. 67, n. 5, p. 521, doi. 10.1002/pros.20548
- By:
- Publication type:
- Article
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 777, doi. 10.1007/s00280-009-0927-7
- By:
- Publication type:
- Article
Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 4, p. 337, doi. 10.1007/s00280-003-0571-6
- By:
- Publication type:
- Article
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00132
- By:
- Publication type:
- Article
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 8, p. 1856, doi. 10.1002/ijc.29212
- By:
- Publication type:
- Article
Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 11, p. 2693, doi. 10.1002/ijc.26303
- By:
- Publication type:
- Article
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 15, p. 2343, doi. 10.1002/cncr.28714
- By:
- Publication type:
- Article
Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 6, p. 885, doi. 10.1002/pbc.23270
- By:
- Publication type:
- Article
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. e984, doi. 10.1093/oncolo/oyae028
- By:
- Publication type:
- Article
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 476, doi. 10.1093/oncolo/oyac035
- By:
- Publication type:
- Article
Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 521, doi. 10.1002/cncr.34576
- By:
- Publication type:
- Article
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 4, p. 1, doi. 10.1093/jnci/dju013
- By:
- Publication type:
- Article